List of Tables

Table 1. Aprepitant Capsules Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Aprepitant Capsules Market Restraints

Table 3. Aprepitant Capsules Market Trends

Table 4. Aprepitant Capsules Industry Policy

Table 5. Global Aprepitant Capsules Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Aprepitant Capsules Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Aprepitant Capsules Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Aprepitant Capsules Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Aprepitant Capsules Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Aprepitant Capsules Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Aprepitant Capsules Mergers & Acquisitions, Expansion Plans

Table 12. Global Aprepitant Capsules Manufacturers Product Type

Table 13. Head Office and Aprepitant Capsules Production Site of Key Manufacturer

Table 14. Aprepitant Capsules Capacity of Major Manufacturers and Future Plan

Table 15. China Aprepitant Capsules Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Aprepitant Capsules Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Aprepitant Capsules Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Aprepitant Capsules Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Aprepitant Capsules Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Aprepitant Capsules Production by Region, 2020-2025, (K Units)

Table 21. Global Aprepitant Capsules Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Aprepitant Capsules Upstream (Raw Materials)

Table 23. Global Aprepitant Capsules Typical Customers

Table 24. Aprepitant Capsules Typical Distributors

Table 25. by Type, Global Aprepitant Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Aprepitant Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Aprepitant Capsules Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Aprepitant Capsules Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Aprepitant Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Aprepitant Capsules Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Aprepitant Capsules Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Aprepitant Capsules Sales Quantity Market Share, 2020-2031

Table 35. Merck Company Information, Head Office, Market Area, and Industry Position

Table 36. Merck Aprepitant Capsules Models, Specifications, and Application

Table 37. Merck Aprepitant Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Merck Company Profile and Main Business

Table 39. Merck Recent Developments

Table 40. Sandoz Company Information, Head Office, Market Area, and Industry Position

Table 41. Sandoz Aprepitant Capsules Models, Specifications, and Application

Table 42. Sandoz Aprepitant Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Sandoz Company Profile and Main Business

Table 44. Sandoz Recent Developments

Table 45. Glenmark Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 46. Glenmark Pharmaceuticals Aprepitant Capsules Models, Specifications, and Application

Table 47. Glenmark Pharmaceuticals Aprepitant Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Glenmark Pharmaceuticals Company Profile and Main Business

Table 49. Glenmark Pharmaceuticals Recent Developments

Table 50. Chia Tai Tianqing Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position

Table 51. Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Models, Specifications, and Application

Table 52. Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Chia Tai Tianqing Pharmaceutical Group Company Profile and Main Business

Table 54. Chia Tai Tianqing Pharmaceutical Group Recent Developments

Table 55. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 56. Qilu Pharmaceutical Aprepitant Capsules Models, Specifications, and Application

Table 57. Qilu Pharmaceutical Aprepitant Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Qilu Pharmaceutical Company Profile and Main Business

Table 59. Qilu Pharmaceutical Recent Developments

Table 60. Camber Pharma Company Information, Head Office, Market Area, and Industry Position

Table 61. Camber Pharma Aprepitant Capsules Models, Specifications, and Application

Table 62. Camber Pharma Aprepitant Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Camber Pharma Company Profile and Main Business

Table 64. Camber Pharma Recent Developments

List of Figures

Figure 1. Aprepitant Capsules Picture

Figure 2. Global Aprepitant Capsules Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Aprepitant Capsules Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Aprepitant Capsules Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Aprepitant Capsules Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Aprepitant Capsules Sales Quantity (K Units) & (2020-2031)

Figure 7. China Aprepitant Capsules Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Aprepitant Capsules Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Aprepitant Capsules Market Share of Global, 2020-2031

Figure 10. Global Aprepitant Capsules Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Aprepitant Capsules Key Participants, Market Share, 2024

Figure 12. Global Aprepitant Capsules Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Aprepitant Capsules Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Aprepitant Capsules Production Market Share & Forecast by Region, 2020-2031

Figure 15. Aprepitant Capsules Industry Chain

Figure 16. Aprepitant Capsules Procurement Model

Figure 17. Aprepitant Capsules Sales Model

Figure 18. Aprepitant Capsules Sales Channels, Direct Sales, and Distribution

Figure 19. 80mg

Figure 20. 125mg

Figure 21. Other

Figure 22. by Type, Global Aprepitant Capsules Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Aprepitant Capsules Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 25. by Type, Global Aprepitant Capsules Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Aprepitant Capsules Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 27. Hospital

Figure 28. Pharmacy

Figure 29. Other

Figure 30. by Application, Global Aprepitant Capsules Consumption Value, 2020-2031, US$ Million

Figure 31. by Application, Global Aprepitant Capsules Revenue Market Share, 2020-2031

Figure 32. by Application, Global Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 33. by Application, Global Aprepitant Capsules Sales Quantity Market Share, 2020-2031

Figure 34. by Application, Global Aprepitant Capsules Price, 2020-2031, (US$/Unit)

Figure 35. By Region, Global Aprepitant Capsules Consumption Value Market Share, 2020-2031

Figure 36. By Region, Global Aprepitant Capsules Sales Quantity Market Share, 2020-2031

Figure 37. North America Aprepitant Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 38. By Country, North America Aprepitant Capsules Consumption Value Market Share, 2024

Figure 39. Europe Aprepitant Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, Europe Aprepitant Capsules Consumption Value Market Share, 2024

Figure 41. Asia Pacific Aprepitant Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country/Region, Asia Pacific Aprepitant Capsules Consumption Value Market Share, 2024

Figure 43. South America Aprepitant Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, South America Aprepitant Capsules Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Aprepitant Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. United States Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 47. by Type, United States Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 48. by Application, United States Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 49. Europe Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 50. by Type, Europe Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, Europe Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 52. China Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 53. by Type, China Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, China Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 55. Japan Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 56. by Type, Japan Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, Japan Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 58. South Korea Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 59. by Type, South Korea Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, South Korea Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 61. Southeast Asia Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 62. by Type, Southeast Asia Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, Southeast Asia Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 64. India Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 65. by Type, India Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, India Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 67. Middle East & Africa Aprepitant Capsules Sales Quantity, 2020-2031, (K Units)

Figure 68. by Type, Middle East & Africa Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, Middle East & Africa Aprepitant Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up Approaches

Figure 73. Top-down Approaches